New-Onset Crohn's Disease following Initiation of Secukinumab: A Case Report and Review of the Role of IL-17 in the Pathogenesis of Crohn's Disease

Patients with autoimmune conditions show a high expression of proinflammatory cytokines including interleukin (IL)-17. While IL-17 inhibitors have demonstrated efficacy in managing autoimmune disorders, rare instances of de novo or exacerbated inflammatory bowel disease (IBD) have been reported. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Khouri, Anas, Moreno, Cesar, Niland, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228216/
https://www.ncbi.nlm.nih.gov/pubmed/37260537
http://dx.doi.org/10.1155/2023/1769290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228216/
https://www.ncbi.nlm.nih.gov/pubmed/37260537
http://dx.doi.org/10.1155/2023/1769290

Ejemplares similares